Finasteridum
Finasteride Medreg contains the active substance finasteride. Finasteride belongs to a group of medicines called 5-alpha-reductase inhibitors.
Finasteride Medreg reduces the size of the prostate gland in men when it is enlarged.
The prostate gland is located below the bladder (this gland is only present in men). It produces a fluid that is present in semen.
An enlarged prostate gland can lead to a condition called benign prostatic hyperplasia or BPH.
If you have been diagnosed with BPH, it means that your prostate gland is enlarged. It can press on the tubes (urethra) through which urine is discharged from the body.
This can lead to problems such as:
In some men, BPH can lead to serious problems, such as:
If you have any questions, you should consult your doctor.
Before starting treatment with Finasteride Medreg, you should discuss it with your doctor or pharmacist:
Mood changes, such as decreased mood, depression, and rarely suicidal thoughts, have been reported in patients treated with Finasteride Medreg. If you experience any of these symptoms, you should stop taking Finasteride Medreg and consult your doctor as soon as possible to receive further medical advice.
If you have any doubts, you should contact your doctor or pharmacist before taking Finasteride Medreg.
Finasteride Medreg should not be used in children.
You should tell your doctor or pharmacist about all medicines you are taking or have recently taken, as well as any medicines you plan to take.
Finasteride Medreg usually does not affect the action of other medicines.
Finasteride Medreg can be taken with or without food.
Finasteride Medreg should not be used in women.
There are no data suggesting that Finasteride Medreg affects the ability to drive or use machines.
If you have been diagnosed with intolerance to some sugars, you should consult your doctor before taking Finasteride Medreg.
This medicine contains less than 1 mmol (23 mg) of sodium per film-coated tablet, which means it is essentially 'sodium-free'.
This medicine should always be taken exactly as prescribed by your doctor. If you are unsure, you should consult your doctor or pharmacist.
If you have taken more than the recommended dose of Finasteride Medreg or if someone else has taken any of your tablets, you should immediately contact the emergency department of your nearest hospital. You should take any remaining tablets or the empty packaging with you to facilitate identification.
Your condition may improve quickly after taking Finasteride Medreg.
It may take about 6 months to achieve the full effect of treatment. It is important to continue taking Finasteride Medreg for as long as your doctor recommends, even if you do not feel any significant improvement.
If you have any further doubts about taking this medicine, you should consult your doctor or pharmacist.
Like all medicines, Finasteride Medreg can cause side effects, although not everybody gets them.
The following frequency categories have been used to classify the side effects:
Common (occurring in less than 1 in 10 patients):
Uncommon (occurring in less than 1 in 100 patients):
Unknown (frequency cannot be estimated from available data):
You should immediately inform your doctor of any changes in your breasts, such as lumps, pain, enlargement, or discharge from the nipple, as these may be signs of a serious condition, such as breast cancer.
If any of the side effects get worse or if you notice any side effects not listed in this leaflet, you should tell your doctor or pharmacist. It will be helpful if you note what happened, when it started, and how long it lasted.
If you experience any side effects, including those not listed in this leaflet, you should tell your doctor or pharmacist, or nurse. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Aleje Jerozolimskie 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
The medicine should be stored out of sight and reach of children.
There are no special precautions for storage.
Do not use this medicine after the expiry date stated on the packaging after EXP.
The expiry date refers to the last day of the month stated.
The inscription on the packaging after the abbreviation EXP means the expiry date, and after the abbreviation Lot means the batch number.
Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Blue, round, film-coated tablets with the inscription "H" on one side and "37" on the other side.
Packaging contains: 7, 10, 14, 15, 20, 28, 30, 49, 50, 56, 60, 84, 90, 98, 100, 112, 120, 250, 300, 500 film-coated tablets.
Not all pack sizes may be marketed.
Medreg s.r.o.
Na Florenci 2116/15
Nové Město
110 00 Prague 1
Czech Republic
Medis International a.s.
Výrobní závod Bolatice
Průmyslová 961/16
747 23 Bolatice
Czech Republic
To obtain more detailed information about this medicine, you should contact the local representative of the marketing authorization holder.
Medreg s.r.o.
Na Florenci 2116/15
Nové Město
110 00 Prague 1
Czech Republic
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.